Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Werden

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|April 23, 2021
Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growthNathalie Sphyris, Cody King, Jonathan Hoar, et al.
Virus Research|May 30, 2009
Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbitsJohn W Barrett, Steven J Werden, Fuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factorGen Wang, John W Barrett, Marianne Stanford, et al.
Virology|December 23, 2006
Myxoma virus M063R is a host range gene essential for virus replication in rabbit cellsJohn W Barrett, Chew Shun Chang, Gen Wang, et al.
Cell Research|January 5, 2011
A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral responseSuzanne Paz, Myriam Vilasco, Steven J Werden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2007
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivoMarianne M Stanford, Mae Shaban, John W Barrett, et al.
Journal of Virology|October 26, 2007
Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18Steven H Nazarian, Masmudur M Rahman, Steven J Werden, et al.
Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|April 23, 2021
Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growthNathalie Sphyris, Cody King, Jonathan Hoar, et al.
Virus Research|May 30, 2009
Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbitsJohn W Barrett, Steven J Werden, Fuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factorGen Wang, John W Barrett, Marianne Stanford, et al.
Virology|December 23, 2006
Myxoma virus M063R is a host range gene essential for virus replication in rabbit cellsJohn W Barrett, Chew Shun Chang, Gen Wang, et al.
Cell Research|January 5, 2011
A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral responseSuzanne Paz, Myriam Vilasco, Steven J Werden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2007
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivoMarianne M Stanford, Mae Shaban, John W Barrett, et al.
Journal of Virology|October 26, 2007
Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18Steven H Nazarian, Masmudur M Rahman, Steven J Werden, et al.
Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.
Pageof 2